13/12/07
Partnership for producing mites recombinant allergens
Partnership agreement between Stallergenes and PROTEIN’EXPERT
28/11/07
Oralair® Grasses: Positive results of VO52.06 paediatric study
The results of a study on children confirmed the efficacy of the ORALAIR® Grasses sublingual desensitisation product, which is due to receive German market authorisation shortly.
12/07/07
2007 1st half-year sales up 17%,Q2 sales up 13%
(€ millions) 2007 2006 07/06 % sales % sales % change Southern Europe (1)23.2272.020.5371.813Other EU countries (2)7.6923.86.9124.211Other...
17/04/07
2007 1st quarter sales up 20%
(€ millions) 2007 % of sales 2006 % of sales07/ 06 % Change Southern Europe(1) 33,3278,327,5777,521Other EU countries8,0719,06,8019,119Other markets1,172,71,223,4(4)SLIT34,6381,427,6677,725SCIT6,1714,56,2717,6(2)Other...
15/03/07
Increase in operating profit and additional R&D efforts
The Board of Directors, meeting on 14 March 2007 under the chairmanship of Albert SAPORTA, approved the 2006 consolidated financial statements prepared in accordance with international accounting standards. Comparative 2005...
13/02/07
Stallergenes enters the Netherlands through a joint-venture agreement
Antony,France (Feb. 13, 2007) 'Stallergenes SA today announced that it has set up a joint-venture in the Netherlands in partnership with the Dutch company Sanmed B.V.
The agreement represents an important step forward in...
15/01/07
Strong 13% 2006 full-year growth,2006 4th quarter sales up 13%
€ millions 2006 2005 % increase Quarter 4 sales 37.46 33.14 13% France, including overseas dependencies19.3316.1819%Subsidiaries (1) 14.0913.306%Distributors (2)4.043.6610%Cumulative sales at end December 126.55 112.04 13%...
